Please assess the completion status of the following clinical trial:

Trial Title: Study of Dual Trigger Ovulation in Oocyte Donors

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~Donors~* Young women, age 21 to 34, presenting to our facility with the desire to donate oocytes and meeting FDA and program requirements for donation.~Recipients~* Women, age 21 to 55, presenting to our facility with the desire to donate oocytes and meeting FDA and program requirements to be recipients of donated eggs.~Exclusion Criteria:~Donors~* Less than 2 ovaries or any other significant ovarian abnormality~* Does not meet current FDA or program requirements for donation.~* A contraindication for the use of gonadotropins (e.g. tumors, pregnancy/lactation, undiagnosed vaginal bleeding, hypersensitivity, clinically significant ovarian cysts)~* A contraindication for the use of oral contraceptive pills (h/o thromboembolism, breast cancer, undiagnosed vaginal bleeding)~* Known gene defects, genetic abnormalities or abnormal karyotype~* Contraindication or hypersensitivity to any of the concomitant medication prescribed as part of the treatment regimen in this protocol~* Inability to give informed consent~* Donors who, because of their place of residence or personal situation, would not be able to commit to all required time points including the one extra visit required by study participation.~* The subject has a recent history of/or current epilepsy, thrombophilia, diabetes, cardiovascular, gastro-intestinal, hepatic, renal or pulmonary or auto-immune disease

- Gender: FEMALE
- Minimum Age: 21 Years
- Maximum Age: 55 Years
- Healthy Volunteers: t

Study Arms:
- hCG (Type: ACTIVE_COMPARATOR): standard dose of hCG for ovulation trigger
- Lupron Trigger (Type: ACTIVE_COMPARATOR): Leuprolide acetate 2 mg ovulation trigger
- Dual Trigger (Type: EXPERIMENTAL): Lupron and hCG combined ovulation trigger

Based on this trial design, predict the completion outcome and termination type (if applicable).